Display options
Cite
Valladares MJ, Rodríguez Sándigo NA, Rizo Rivera GO, et al. Prevalence, awareness, treatment, and control of hypertension in a small northern town in Nicaragua: The Elieth-HIFARI study. Health Sci Rep. 2019;2(7):e120doi: 10.1002/hsr2.120.
Valladares, M. J., Rodríguez Sándigo, N. A., Rizo Rivera, G. O., Rodríguez Jarquín, M. A., Rivera Castillo, R. M., & López Bonilla, I. M. (2019). Prevalence, awareness, treatment, and control of hypertension in a small northern town in Nicaragua: The Elieth-HIFARI study. Health science reports, 2(7), e120. https://doi.org/10.1002/hsr2.120
Valladares, Marion Jose, et al. "Prevalence, awareness, treatment, and control of hypertension in a small northern town in Nicaragua: The Elieth-HIFARI study." Health science reports vol. 2,7 (2019): e120. doi: https://doi.org/10.1002/hsr2.120
Valladares MJ, Rodríguez Sándigo NA, Rizo Rivera GO, Rodríguez Jarquín MA, Rivera Castillo RM, López Bonilla IM. Prevalence, awareness, treatment, and control of hypertension in a small northern town in Nicaragua: The Elieth-HIFARI study. Health Sci Rep. 2019 Apr 11;2(7):e120. doi: 10.1002/hsr2.120. eCollection 2019 Jul. PMID: 31346554; PMCID: PMC6636515.
Copy Download .nbib Format: NLM
Share it on

Health Sci Rep. 2019 Apr 11;2(7):e120. doi: 10.1002/hsr2.120. eCollection 2019 Jul.

Prevalence, awareness, treatment, and control of hypertension in a small northern town in Nicaragua: The Elieth-HIFARI study.

Health science reports

Marion Jose Valladares, Noel A Rodríguez Sándigo, Ginner O Rizo Rivera, Marco A Rodríguez Jarquín, Rosse M Rivera Castillo, Indiana M López Bonilla

Affiliations

  1. Faculty of Medical Sciences UNAN-Leon León Nicaragua.
  2. ELAM Cuba Victoria Motta Hospital Jinotega Nicaragua.
  3. Medicine Faculty UNAN-Managua Managua Nicaragua.
  4. Medicine Faculty UCATSE Estelí Nicaragua.
  5. Research Centre on Health, Work and Environment UNAN-Leon León Nicaragua.

PMID: 31346554 PMCID: PMC6636515 DOI: 10.1002/hsr2.120

Abstract

BACKGROUND AND AIMS: Hypertension is considered the most important risk factor for cardiovascular disease and is associated with high levels of morbidity, mortality, and health care expenditure. The negative effects of hypertension and its complications are preventable if those at risk are appropriately treated and controlled. Continually monitoring the epidemiological trends of hypertension is essential to formulate and evaluate public health measures to limit its negative effects. The herein presented Elieth-HIFARI study sought to estimate the prevalence of hypertension, as well as the prevalence of related awareness, treatment, and control in a small town in Central America.

METHODS: A population survey to assess cardiovascular risk was conducted (n = 577, 55.3% women, mean age 42.4 years) in the municipality of San Rafael del Norte in northern Nicaragua, between November 2016 and March 2017, based on the STEPwise method by the World Health Organization and the recommendations by the World Hypertension League.

RESULTS: The overall prevalence of hypertension, awareness, treatment, and control was 28.1%, 72.2%, 68.5%, and 36.4%, respectively. Men had a lower prevalence of all indicators (22.5%, 60.3%, 53.4%, and 24.1%, respectively) compared with women (32.6%, 78.8%, 76.9%, and 43.3%, respectively). The median systolic blood pressure was 118.5 mm Hg (20.5 interquartile range [IQR]) (men: 123.0 mm Hg vs women: 115.5 mm Hg, Mann-Whitney U test

CONCLUSION: Hypertension is highly prevalent in San Rafael del Norte, while control rates are low despite the relatively higher levels of awareness and treatment. Furthermore, women have much higher prevalence of hypertension than men, along with higher awareness, treatment, and control. However, the control rate for those treated for hypertension was low, irrespective of sex.

Keywords: cardiovascular disease; control rate; high blood pressure; hypertension; prevalence

Conflict of interest statement

The authors have nothing to disclose.

References

  1. J Hypertens. 2001 Sep;19(9):1523-32 - PubMed
  2. Circulation. 2005 Feb 8;111(5):697-716 - PubMed
  3. CMAJ. 1992 Jun 1;146(11):1997-2005 - PubMed
  4. J Hypertens. 2010 Jan;28(1):24-34 - PubMed
  5. Lancet. 2010 Nov 27;376(9755):1861-8 - PubMed
  6. Vasc Health Risk Manag. 2011;7:709-17 - PubMed
  7. Ethn Dis. 2012 Spring;22(2):129-35 - PubMed
  8. Lancet. 2012 Dec 15;380(9859):2224-60 - PubMed
  9. Am J Hypertens. 2014 Nov;27(11):1355-61 - PubMed
  10. Scand J Public Health. 2014 Aug;42(6):504-10 - PubMed
  11. J Clin Hypertens (Greenwich). 2014 Nov;16(11):773-81 - PubMed
  12. J Clin Hypertens (Greenwich). 2015 May;17(5):381-8 - PubMed
  13. J Hum Hypertens. 2015 Nov;29(11):696-701 - PubMed
  14. Appl Nurs Res. 2016 Feb;29:43-6 - PubMed
  15. Am J Hypertens. 2016 Dec 1;29(12):1343-1352 - PubMed

Publication Types